Drug Screening Market Analysis and Forecast to 2031: By Products & Service (Drug Screening Product, Analytical Instruments, Rapid Testing Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service), Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Others), End User (Drug Testing Laboratories, Workplaces, Criminal Justice & Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools & Colleges), and Region

The global drug screening market was valued at USD 5.6 billion in 2021 and it is expected to reach up to USD 25.3 billion by 2031, at a CAGR of 16.3% during the projection period.

Drug screening is the process of recognizing illicit and some recommended drugs in the blood, urine, and other biological samples. A drug screening process is also called the analysis and detection of performance-enhancing drugs consumed by professional athletes like steroids and HGH in order to improve stamina and performance at the time of the sport.

Some of the major illegal drugs include heroin, cannabis, cocaine, methamphetamines, methadone, and amphetamine. The rising incidence of such drugs consumptions across the world is the major concern being faced by many governments. For example, according to National Institute on Drug Abuse (NIDA), in 2010, an estimated 22.6 million of the population were illicit drug users in the U.S, which accounted for an estimated 8.9% of the total population of the country.

Global Drug Screening Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$5.6 bn
Market Size in 2031$25.3 bn
Growth Rate (2021-31)16.3%
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredProduct & Services, Sample Type, End User, and Region
Key CompaniesLabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens Healthineers (Germany), Roche (Switzerland), MPD Inc. (US), Shimadzu (Japan)
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The key factor boosting the growth of the market is growing drug and alcohol consumption. Drug abuse and alcohol consumption are increasing worldwide. According to the World Drug Report 2021, in 2019, an estimated 275 million people across the globe aged 15–64, or 1 in every 18 people in that age group, have used drugs at least once in the previous year. In the same year, drug use killed almost half a million people, while drug use disorders resulted in 18 million years of healthy life lost, mainly owing to opioids. Alcohol consumption has shown similar increases, with consequences witnessed in the growing incidence of impaired driving. The increasing consumption of illicit drugs & alcohol will further boost the development of drug screening products & services on the road, thereby driving the overall market growth.

Market Restraints and Challenges

The key factor hindering the growth of the market is the prohibition of workplace drug testing in some countries. Some countries like Canada, Colombia, Argentina, Chile, and South Africa, consider drug & alcohol testing at the workplace to be a violation of employee privacy. For example, pre-employment drug testing is only performed in France when physicians recommend the test. In Poland and the Czech Republic, drug & alcohol tests in the workplace are prohibited. In Canada, the Eastern Canadian case laws permit drug & alcohol testing only when workplace operations are fundamentally dangerous or where drug and alcohol testing is limited to a few special cases. Such prohibitions in various countries may hamper the adoption of drug & alcohol testing in these markets, so restraining overall market growth to a certain extent.

Global Drug Screening Market Segmental Overview

The report analyses the global drug screening market based on the products & services, sample type, end users, and regions.

Global Drug Screening Market by Products & Services

Based on products & services, it is segmented into drug screening products, analytical instruments, rapid testing devices, oral fluid testing devices, oral fluid testing devices, consumables, and drug screening services. The drug screening products segment is likely to dominate the market during the forecast period. The growing drug and alcohol consumption coupled with the enforcement of stringent laws mandating drug & alcohol testing is boosting the growth of the market.

Global Drug Screening Market by Sample Type

Based on sample type, it is segmented into urine samples, breath samples, oral fluid samples, hair samples, and others. The urine samples segment is likely to dominate the market during the forecast period. The key factors attributing to the growth of the market are the enforcement of stringent law mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services are boosting the growth of the market.

Global Drug Screening Market by End Users

Based on end users, it is segmented into drug testing laboratories, workplaces, criminal justice & law enforcement agencies, hospitals, drug treatment centers, individual users, pain management centers, school & colleges. The drug testing laboratories segment is likely to boost the market growth during the forecast period. The key factors boosting the growth of the market are stringent regulations by government agencies mandating alcohol and drug testing for safety purposes and increasing initiatives to monitor and combat substance abuse are likely to boost the growth of the market.

Geographical Analysis of Global Drug Screening Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is likely to dominate the market during the forecast period. The key factor attributed to the growth of the market is the growing consumption of illicit drugs, the availability of government funding to curb abuse, laws supporting drug screening, the growing burden of accidents owing to alcohol impairment, and the presence of key players in the region are boosting the growth of the market.

Major Players in the Global Drug Screening Market

The key players studied in the global drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens Healthineers (Germany), Roche (Switzerland), MPD Inc. (US), Shimadzu (Japan), LifeLoc Technologies (US), Drägerwerk (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics (US), Clinical Reference Laboratory (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Synens (France), Intoximeters (US), AccuSource (US), Cordant Health Solutions (US), Millennium Health (US).

Recent Developments
  • August 2021, Quest Diagnostics and Select Health of South Carolina entered into an agreement to expand Select Health’s laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees and to enhance access to diagnostics information services for members.
  • September 2020, Lab Corp entered into a multi-year agreement with Infirmary Health to offer laboratory testing services in the Eastern Gulf Coast.
  • May 2020, Psychemedics introduced a vaping panel test that detects the ingestion of marijuana, CBD, and nicotine drugs by all methods, comprising electronic cigarettes or smoking.
  • April 2019, Thermo Fisher Scientific introduced CEDIA Mitragynine Assay for the detection of Kratom for criminal justice and forensic use only.
  • May 2018, Omega Laboratories introduced the Omega Hair 17 panel drug test capable of detecting 45 different substances, comprising eight commonly abused variants of benzodiazepines.
Frequently Asked Questions

Q1. How big is the Drug Screening market?

Ans. The global Drug Screening market size was USD 5.6 Billion in 2021 and is anticipated to reach USD 25.3 Billion in 2031, growing at a rate of 16.3% from 2022 to 2031.

Q2. What is the Drug Screening market growth rate?

Ans. The growth rate of the Drug Screening market is 16.3% from 2022 to 2031.

Q3. Which region holds a major market share for the Drug Screening market?

Ans. North America holds a major market share of the Drug Screening market in 2021.

Q4. Which segment accounted for the largest Drug Screening market share?

Ans. By end user, the drug testing laboratories segment accounted for the largest Drug Screening market share.

Q5. Who are the key players in the Drug Screening market?

Ans. The global Drug Screening market report includes players such as LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), Thermo Fisher Scientific, Inc. (US), Alfa Scientific Designs, Inc. (US), OraSure Technologies, Inc. (US), Siemens Healthineers (Germany), Roche (Switzerland), MPD Inc. (US), Shimadzu (Japan), LifeLoc Technologies (US), Drägerwerk (Germany), Premier Biotech, Inc. (US), Omega Laboratories, Inc. (US), Psychemedics (US), Clinical Reference Laboratory (US), American Bio Medica Corporation (US), ACM Global Laboratories (US), CareHealth America Corp (US), Sciteck, Inc. (US), Synens (France), Intoximeters (US), AccuSource (US), Cordant Health Solutions (US), Millennium Health (US).

Q6. What are the factors driving the Drug Screening market growth?

Ans. The major factors driving the growth of the market are growing drug and alcohol consumption.

Q7. What are the key growth strategies of Drug Screening market players?

Ans. The key growth strategies of Drug Screening market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Drug Screening market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Drug Screening market during the forecast period.

Table of Contents

Chapter 1. Market Introduction
1.1. Objectives of the study
1.2. Market definition and research & scope
1.3. Research methodologies
1.4. Market estimation techniques

Chapter 2. Executive summary
2.1. Summary
2.2. Key highlights of the market

Chapter 3. Drug Screening market outlook
3.1. Drug Screening market segmentation
3.2. Market dynamics
3.2.1. Market drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s five forces analysis
3.3.1. Threat of new entrants
3.3.2. Threat of substitutes
3.3.3. Bargaining power of buyers
3.3.4. Bargaining power of supplier
3.3.5. Competitive rivalry
3.4. Pestle analysis
3.5. Value chain analysis
3.5.1. Raw material suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or retailers
3.6. Impact of the Russia and Ukraine war on the global Drug Screening market

Chapter 4. The economic impact of covid-19
4.1. Overall impact of covid-19
4.2. Impact of covid on the global Drug Screening market
4.3. Economic impact analysis

Chapter 5. Drug Screening Market by Product & Service
5.1. Market overview
5.2. Drug Screening Product
5.2.1. Market size and forecast, 2021-2031 ($million)
5.2.2. Market size and forecast, by region, 2021-2031 ($million)
5.3. Analytical Instruments
5.3.1. Market size and forecast, 2021-2031 ($million)
5.3.2. Market size and forecast, by region, 2021-2031 ($million)
5.4. Rapid Testing Devices
5.4.1. Market size and forecast, 2021-2031 ($million)
5.4.2. Market size and forecast, by region, 2021-2031 ($million)
5.5. Oral Fluid Testing Devices
5.5.1. Market size and forecast, 2021-2031 ($million)
5.5.2. Market size and forecast, by region, 2021-2031 ($million)
5.6. Consumables
5.6.1. Market size and forecast, 2021-2031 ($million)
5.6.2. Market size and forecast, by region, 2021-2031 ($million)
5.7. Drug Screening Services
5.7.1. Market size and forecast, 2021-2031 ($million)
5.7.2. Market size and forecast, by region, 2021-2031 ($million)

Chapter 6. Drug Screening market by Sample Type
6.1. Market overview
6.2. Urine Samples
6.2.1. Market size and forecast, 2021-2031 ($million)
6.2.2. Market size and forecast, by region, 2021-2031 ($million)
6.3. Breath Samples
6.3.1. Market size and forecast, 2021-2031 ($million)
6.3.2. Market size and forecast, by region, 2021-2031 ($million)
6.4. Oral Fluid Samples
6.4.1. Market size and forecast, 2021-2031 ($million)
6.4.2. Market size and forecast, by region, 2021-2031 ($million)
6.5. Hair Samples
6.5.1. Market size and forecast, 2021-2031 ($million)
6.5.2. Market size and forecast, by region, 2021-2031 ($million)
6.6. Others
6.6.1. Market size and forecast, 2021-2031 ($million)
6.6.2. Market size and forecast, by region, 2021-2031 ($million)

Chapter 7. Drug Screening market by End Users
7.1. Market overview
7.2. Drug Testing Laboratories
7.2.1. Market size and forecast, 2021-2031 ($million)
7.2.2. Market size and forecast, by region, 2021-2031 ($million)
7.3. Workplaces
7.3.1. Market size and forecast, 2021-2031 ($million)
7.3.2. Market size and forecast, by region, 2021-2031 ($million)
7.4. Criminal Justice and Law Enforcement Agencies
7.4.1. Market size and forecast, 2021-2031 ($million)
7.4.2. Market size and forecast, by region, 2021-2031 ($million)
7.5. Hospitals
7.5.1. Market size and forecast, 2021-2031 ($million)
7.5.2. Market size and forecast, by region, 2021-2031 ($million)
7.6. Drug Treatment Centers
7.6.1. Market size and forecast, 2021-2031 ($million)
7.6.2. Market size and forecast, by region, 2021-2031 ($million)
7.7. Individual Users
7.7.1. Market size and forecast, 2021-2031 ($million)
7.7.2. Market size and forecast, by region, 2021-2031 ($million)
7.8. Pain Management Centers
7.8.1. Market size and forecast, 2021-2031 ($million)
7.8.2. Market size and forecast, by region, 2021-2031 ($million)
7.9. School & Colleges
7.9.1. Market size and forecast, 2021-2031 ($million)
7.9.2. Market size and forecast, by region, 2021-2031 ($million)

Chapter 8. Global Drug Screening market, by region
8.1. Overview
8.2. North America
8.2.1. Key market trends and opportunities
8.2.2. North America Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.2.3. North America Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.2.4. North America Drug Screening market size and forecast by country, 2021-2031, ($million)
8.2.5. The u.s.
8.2.5.1. The u.s. Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.2.5.2. The u.s. Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.2.6. Canada
8.2.6.1. Canada Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.2.6.2. Canada Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.2.7. Mexico
8.2.7.1. Mexico Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.2.7.2. Mexico Drug Screening market size and forecast by End User Products & services, 2021-2031, ($million)
8.3. Europe
8.3.1. Key market trends and opportunities
8.3.2. Europe Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.3. Europe Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.3.4. Europe Drug Screening market size and forecast by country, 2021-2031, ($million)
8.3.5. Germany
8.3.5.1. Germany Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.5.2. Germany Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.3.6. France
8.3.6.1. France Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.6.2. France Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.3.7. U.k.
8.3.7.1. U.k. Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.7.2. U.k. Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.3.8. Spain
8.3.8.1. Spain Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.8.2. Spain Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.3.9. Italy
8.3.9.1. Italy Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.9.2. Italy Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.3.10. Russia
8.3.10.1. Russia Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.10.2. Russia Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.3.11.2. Rest of Europe Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.4. Asia-pacific
8.4.1. Key market trends and opportunities
8.4.2. Asia-pacific Drug Screening market size and forecast by country, 2021-2031, ($million)
8.4.3. Asia-pacific Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.4.4. Asia-pacific Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.4.5. China
8.4.5.1. China Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.4.5.2. China Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.4.6. India
8.4.6.1. India Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.4.6.2. India Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.4.7. Japan
8.4.7.1. Japan Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.4.7.2. Japan Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.4.8. South Korea
8.4.8.1. South Korea Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.4.8.2. South Korea Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.4.9. Rest of APAC
8.4.9.1. Rest of APAC Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.4.9.2. Rest of APAC Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.5. Rest of the world
8.5.1. Key market trends and opportunities
8.5.2. Rest of the world Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.5.3. Rest of the world Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.5.4. Rest of the world Drug Screening market size and forecast by country, 2021-2031, ($million)
8.5.5. Latin America
8.5.5.1. Latin America Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.5.5.2. Latin America Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.5.6. Middle east
8.5.6.1. Middle east Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.5.6.2. Middle east Drug Screening market size and forecast by End User, 2021-2031, ($million)
8.5.7. Africa
8.5.7.1. Africa Drug Screening market size and forecast by Products & services, 2021-2031, ($million)
8.5.7.2. Africa Drug Screening market size and forecast by End User, 2021-2031, ($million)

Chapter 9. Competitive landscape
9.1. Market overview
9.2. Market share analysis/key player positioning
9.3. Developmental strategy benchmarking
9.3.1. New End User development
9.3.2. Products & services launches
9.3.3. Business expansions
9.3.4. Partnerships, joint ventures, and collaborations
9.3.5. Mergers and acquisitions

Chapter 10. Company profiles
10.1. LabCorp (US)
10.1.1. Company snapshot
10.1.2. Financial performance
10.1.3. Products & services offerings
10.1.4. Key strategic initiatives
10.1.5. SWOT analysis
10.2. Quest Diagnostics (US)
10.2.1. Company snapshot
10.2.2. Financial performance
10.2.3. Products & services offerings
10.2.4. Key strategic initiatives
10.2.5. SWOT analysis
10.3. Abbott Laboratories (US)
10.3.1. Company snapshot
10.3.2. Financial performance
10.3.3. Products & services offerings
10.3.4. Key strategic initiatives
10.3.5. SWOT analysis
10.4. Thermo Fisher Scientific, Inc. (US)
10.4.1. Company snapshot
10.4.2. Financial performance
10.4.3. Products & services offerings
10.4.4. Key strategic initiatives
10.4.5. SWOT analysis
10.5. Alfa Scientific Designs, Inc. (US)
10.5.1. Company snapshot
10.5.2. Financial performance
10.5.3. Products & services offerings
10.5.4. Key strategic initiatives
10.5.5. SWOT analysis
10.6. OraSure Technologies, Inc. (US)
10.6.1. Company snapshot
10.6.2. Financial performance
10.6.3. Products & services offerings
10.6.4. Key strategic initiatives
10.6.5. SWOT analysis
10.7. Siemens Healthineers (Germany)
10.7.1. Company snapshot
10.7.2. Financial performance
10.7.3. Products & services offerings
10.7.4. Key strategic initiatives
10.7.5. SWOT analysis
10.8. Roche (Switzerland)
10.8.1. Company snapshot
10.8.2. Financial performance
10.8.3. Products & services offerings
10.8.4. Key strategic initiatives
10.8.5. SWOT analysis
10.9. MPD Inc. (US)
10.9.1. Company snapshot
10.9.2. Financial performance
10.9.3. Products & services offerings
10.9.4. Key strategic initiatives
10.9.5. SWOT analysis
10.10. Shimadzu (Japan)
10.10.1. Company snapshot
10.10.2. Financial performance
10.10.3. Products & services offerings
10.10.4. Key strategic initiatives
10.10.5. SWOT analysis
*the list of company is subject to change during the final compilation of the report

Market Segments

By Product & Services

  • Drug Screening Product
  • Analytical Instruments
  • Rapid Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Drug Screening Service

By Sample Type

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Others

By End User

  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice & Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • School and Colleges

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

The whole slide imaging market was valued at…
Radiology Information Systems (RIS) are specialized computer systems…
Veterinary excipients are inactive substances that are added…
Medical device outsourcing is the process of contracting…
Mammography is a special type of x-ray that…
An endoscope is a long, thin, flexible tube…
ECG cables and lead wires are medical cables…
Pregnancy medication is medication that is taken during…
Healthcare education is the process of providing educational…
Digital Therapeutics is an emerging field that uses…